| Details | | Publication Date: | 1995-09-01 | | Series: | Medical Intelligence Unit Series |
| Size | | Length: | 126 pages | | Height: | 10.5 in | | Width: | 7.5 in | | Thickness: | 0.5 in | | Weight: | 20.8 oz |
Industry Reviews Traces the 13 years of research at Bristol, England, towards the development of a vaccine for the Epstein-Barr virus, a herpesvirus that is present in at least 95% of the human population but is increasingly being linked to a number of cancers. Reviews what is known about the general biology and molecular biology of the virus and the diseases associated with it, and points out the gaps in knowledge that make designing a vaccine difficult. Explains the various approaches to vaccine development, emphasizing the most common, based on the major EBV envelope glycoprotein gp340, but also the recent attempts to rile up cytotoxic T cells against virus antigens. Annotation copyright Book News, Inc. Portland, Or. SciTech Book News
| See an error? Submit a change request |